MedTrace Logo

Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients

NCT02039518 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2014-01-17

No results posted yet for this study

Summary

The purpose of this study is to Evaluate and compare safety and efficacy of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients Receiving Etoposide Combined With Platinum Based First-line Chemotherapy

Conditions

Interventions

DRUG

gemcitabine

gemcitabine 1000mg/m2，d1，d8，Q3W

OTHER

observation group

observation group

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • WU X HUA, DOCTOR · Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02039518 on ClinicalTrials.gov